Synthèse de Molécules d’Intérêt Thérapeutique (SMITh)

Equipe de recherche
RESPONSABLE CO-RESPONSABLE
Benoît Joseph
benoit.joseph@univ-lyon1.fr
04 72 44 81 35
Guy Fournet
guy.fournet@univ-lyon1.fr
04 72 43 14 14  

CHAMPS D’EXPERTISE

medicinal chemistry, heterocyclic chemistry, anticancer agents, protein kinase inhibitors, ALDH inhibitors, alternative splicing modulators, antibody drug-conjugates, drug candidates, pharmacological tools

ACTIVITES DE RECHERCHE / SERVICES

Organic synthesis towards the developement of new chemotherapeutic agents to treat cancer is the mainstream of our team. The aim of our research works is to provide chemical solution (pharmacological tools or drug candidates) to this issues from drug design to the evaluation in vitro and in vivo. Research challenges include: protein kinase inhibitors, alternative splicing modulators and antibody drug conjugates,…

COMPETENCES / MOYENS TECHNIQUES

Methodologies in heterocyclic chemistry, multi-step organic synthesis, small-weight molecule library in house

OU NOUS TROUVER ?

UMR 5246 Institut de Chimie et Biochimie Moléculaires et Supramoléculaires (ICBMS)
43 Boulevard du 11 novembre 1918
69622 Villeurbanne
www.icbms.fr